The following laboratory values were established:  

 

o The differential blood count using whole-blood

o Serotonin daytime level from the blood serum (8 a.m.-9:00 a.m.)

o Melatonin and from the blood serum (daytime level)

o Determination of the nocturnal maximum melatonin excretion through determination of the melatonin metabolite
6-Hydroxy-Melatonin-Sulphate (6-OH-M-S) in the nocturnal total collected urine.

 

It is established that both, the "mood hormone" serotonin and also the "sleep-" and "immune defence hormone"  melatonin is formed in the pineal gland of the brain, whereby serotonin represents a precursor of melatonin.

 

In healthy conditions a maximum of the sleep hormone melatonin is formed from serotonin during the night, whilst, during the daytime, the ‘mood hormone' serotonin is shown to be clearly increased, at the expense of the then severely reduced amount of the ‘sleep hormone', melatonin.

 

In addition, undisturbed melatonin excretion synchronises various biological and hormonal rhythms in the human body and ensures deep revitalising sleep.

 

At the same time, melatonin represents one of the most important immune enhancing substances of our body and, as a free radical scavenger, it protects all body and brain cells against genetic damage considered as a precursor to cancer.

 

Serotonin acts especially as a messenger for the nervous system and in the brain as a mood hormone. A reduction of the serotonin level is therefore associated with depression, lethargy and listlessness, inner agitation and many psychiatric disturbances.

The evaluation/analysis  of 25 study participants (13 women, 9 men, 3 young people) who all live within a radius of 15-300 metres of the telecommunications mast produced the following results:

 

Melatonin in the Urine:

 

Only 8 out of 25 participants (28%) at the initial testing exhibited initial blood levels which were in the region considered to be normal. It was therefore a group of people that had already been pre-exposed.

 

For 14 of 25 participants (56%), there was a decrease for the 6-OH-M-S in the collected nocturnal urine.

 

For 7 of 25 participants (28%), there was an increase, in most cases, within a region considered to be severely pathological.

 

Only one out of 25 participants (4%) with normal initial level exhibited an increased level of 6-OH-M-S at the 2nd [blood] test.

 

 

Daytime melatonin in the blood serum:

 

As a rule, the daytime melatonin level in the blood serum is very much lower than the nocturnal maximum melatonin level.

 

The paradox increase in the daytime melatonin levels reflects the general tendency to marked daytime tiredness of people exposed to radiation.

 

Melatonin levels clearly increased on average by about 4.5 times of the initial level for all 25 participants.

This effect is shown below based on the mean value (of 25 participants).

 

Graph 1

Melatonin in the serum

 

 

Serotonin in the blood:

 

At the second measurement 21 of 25 participants (=84%) presented a reduction  of the ‘mood hormone' serotonin (in the daytime blood serum) by an average of 46.3%.

 

Of these, 10 participants showed a decrease of about 50% and above, with a maximum serotonin decrease of up to 68 %. For 3 participants it remained unchanged, for 1 participant the level was slightly increased.

 

The following graph shows this change based on the mean value of 21 participants:

 

Graph 2

Serotonin in the Serum